Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
65 rows where has_cryoEM = 1, in_cev_map = 0 and surface_class = "A_assoc" sorted by evidence_priority descending
This data as json, CSV (advanced)
Suggested facets: pdb_count_total, aptamer_count_pubmed
surface_class 1
- A_assoc · 65 ✖
in_cev_map 1
- - · 65 ✖
has_structure 1
- 1 65
has_cryoEM 1
- 1 · 65 ✖
has_activation_state_pdb_pair 1
- 0 65
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Q00604 | NDP | Norrin | Tier 1.5 | 0.707 | 1 | A_assoc | 11 | 83.56 | 1 | 0 | 1 | 2 | 39057719, 11352723 | 0 | Norrie disease | 0.8566451682188412 | ||
| O95970 | LGI1 | Leucine-rich glioma-inactivated protein 1 | Tier 1.5 | 0.697 | 1 | A_assoc | 9 | 92.56 | 1 | 0 | 0 | 0 | 0 | autosomal dominant epilepsy with auditory features | 0.8225657483127345 | |||
| P29460 | IL12B | Interleukin-12 subunit beta | Tier 1 | 0.687 | 1 | A_assoc | 20 | 91.12 | 1 | 0 | 0 | 0 | 0 | psoriasis | 0.7914863943708039 | |||
| P03971 | AMH | Anti-Muellerian hormone | Tier 1.5 | 0.685 | 1 | A_assoc | 3 | 68.62 | 1 | 0 | 1 | 2 | 41101154, 27364573 | 0 | persistent Mullerian duct syndrome | 0.7847328444470535 | ||
| P05019 | IGF1 | Insulin-like growth factor 1 | Tier 1 | 0.68 | 1 | A_assoc | 32 | 59.53 | 1 | 0 | 1 | 23 | 38384162, 35859339, 35591468, 33977395, 33467925, 32511241, 31930684, 26245346, 24832383, 23933187, 23373648, 16019422, 41283885, 39263947, 38497478, 33888746, 15231297 | 0 | growth delay due to insulin-like growth factor type 1 deficiency | 0.7650418939376437 | ||
| Q9GZV9 | FGF23 | Fibroblast growth factor 23 | Tier 1 | 0.679 | 1 | A_assoc | 6 | 76.62 | 1 | 0 | 1 | 11 | 39007037, 38079395, 35415885, 32065590, 30297602, 30197987, 41226313, 36705086 | 0 | autosomal dominant hypophosphatemic rickets | 0.762326334964193 | ||
| P35225 | IL13 | Interleukin-13 | Tier 1 | 0.669 | 1 | A_assoc | 13 | 85.62 | 1 | 0 | 1 | 9 | 41463156, 35356877, 33742062, 32784904, 27640094, 29949702, 21793788 | 0 | atopic eczema | 0.7297489019498119 | ||
| Q2MKA7 | RSPO1 | R-spondin-1 | Tier 1 | 0.669 | 1 | A_assoc | 12 | 74.69 | 1 | 0 | 0 | 0 | 0 | palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome | 0.7285342885472184 | |||
| P05305 | EDN1 | Endothelin-1 | Tier 1 | 0.666 | 1 | A_assoc | 17 | 65.19 | 1 | 0 | 1 | 2 | 40438585, 37198662 | 0 | auriculocondylar syndrome | 0.7193561828311311 | ||
| P12272 | PTHLH | Parathyroid hormone-related protein | Tier 1 | 0.666 | 1 | A_assoc | 11 | 62.88 | 1 | 0 | 0 | 0 | 0 | brachydactyly type E | 0.7203484375635054 | |||
| P01270 | PTH | Parathyroid hormone | Tier 1 | 0.664 | 1 | A_assoc | 26 | 72.12 | 1 | 0 | 1 | 9 | 40464222, 40108760, 39880691, 38079395, 25901535, 41303575, 41226313 | 0 | hypoparathyroidism, familial isolated 1 | 0.7147450451832739 | ||
| Q8N300 | SVBP | Small vasohibin-binding protein | Tier 1 | 0.649 | 1 | A_assoc | 24 | 85.06 | 1 | 0 | 0 | 0 | 0 | neurodevelopmental disorder with ataxia, hypotonia, and microcephaly | 0.6640118055835142 | |||
| O95631 | NTN1 | Netrin-1 | Tier 1.5 | 0.648 | 1 | A_assoc | 5 | 88.5 | 1 | 0 | 0 | 0 | 0 | mirror movements 4 | 0.6611393488240481 | |||
| P05113 | IL5 | Interleukin-5 | Tier 1 | 0.642 | 1 | A_assoc | 5 | 86.69 | 1 | 0 | 1 | 12 | 40972397, 35487180, 35356877, 34831332, 32784904, 32038731, 29881374, 28062796, 26048585 | 0 | asthma | 0.6399821251487101 | ||
| Q16552 | IL17A | Interleukin-17A | Tier 1 | 0.641 | 1 | A_assoc | 44 | 84.31 | 1 | 0 | 1 | 30 | 42017161, 41754778, 41482938, 41477217, 40410820, 39376102, 38091227, 38031342, 37879125, 37238999, 36517803, 36375248, 36326540, 35724603, 32784904, 32387307, 31316164, 27827561, 24056860, 21524680, 20967861, 37563071, 34531951 | 0 | psoriasis | 0.6367521314106471 | ||
| Q9UHF0 | TAC3 | Tachykinin-3 | Tier 1 | 0.63 | 1 | A_assoc | 2 | 64.88 | 1 | 0 | 0 | 0 | 0 | hypogonadotropic hypogonadism 10 with or without anosmia | 0.5995324402695232 | |||
| Q6IBW4 | NCAPH2 | Condensin-2 complex subunit H2 | Tier 1.5 | 0.62 | 1 | A_assoc | 1 | 62.41 | 1 | 0 | 0 | 0 | 0 | cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1 | 0.5674645203025676 | |||
| P07492 | GRP | Gastrin-releasing peptide | Tier 1 | 0.619 | 1 | A_assoc | 9 | 63.94 | 1 | 0 | 1 | 6 | 38890976, 38659329, 37500079, 29027923, 41810845, 23179274 | 0 | type 2 diabetes mellitus | 0.5648167305980163 | ||
| Q15726 | KISS1 | Metastasis-suppressor KiSS-1 | Tier 1.5 | 0.618 | 1 | A_assoc | 2 | 59.41 | 1 | 0 | 1 | 1 | 35026192 | 0 | hypogonadotropic hypogonadism | 0.5608645918536114 | ||
| P22466 | GAL | Galanin peptides | Tier 1.5 | 0.613 | 1 | A_assoc | 10 | 66.56 | 1 | 0 | 1 | 27 | 40382399, 40371468, 39772541, 39705316, 39681229, 39430968, 39329806, 39263318, 38487245, 38314707, 37737989, 37610431, 37512948, 36795559, 36194889, 34944985, 34635237, 33769582, 33006019, 32502344, 31778957, 31173420, 30650243, 29808997, 25940316, 21850727, 9546673 | 0 | temporal lobe epilepsy | 0.5442263564708273 | ||
| P56704 | WNT3A | Protein Wnt-3a | Tier 1 | 0.608 | 1 | A_assoc | 4 | 88.31 | 1 | 0 | 1 | 1 | 37231925 | 0 | neurodegenerative disease | 0.5271953966006525 | ||
| O00585 | CCL21 | C-C motif chemokine 21 | Tier 1 | 0.608 | 1 | A_assoc | 5 | 72.69 | 1 | 0 | 1 | 2 | 36314402, 29733244 | 0 | rheumatoid arthritis | 0.5266345093424485 | ||
| P78556 | CCL20 | C-C motif chemokine 20 | Tier 1 | 0.6 | 1 | A_assoc | 6 | 88.69 | 1 | 0 | 1 | 1 | 36375248 | 0 | inflammatory bowel disease | 0.4987938599485985 | ||
| P60568 | IL2 | Interleukin-2 | Tier 1 | 0.6 | 1 | A_assoc | 37 | 84.12 | 1 | 0 | 1 | 45 | 41754959, 40972397, 40761795, 40447990, 38081519, 37805109, 37141264, 37110712, 37074914, 34511903, 34386332, 32784904, 32574155, 32280743, 31383650, 31270926, 30800133, 29556342, 29055191, 28129128, 27959341, 27878687, 27819142, 27529794, 27179422, 26048585, 25919090, 24682172, 35756119, 30883749, 29244152, 24968026, 24418663, 18319343, 12900522 | 0 | asthma | 0.5009876866575907 | ||
| P10997 | IAPP | Islet amyloid polypeptide | Tier 1 | 0.589 | 1 | A_assoc | 76 | 78.31 | 1 | 0 | 1 | 9 | 40602090, 26881276, 25659966, 18090326, 16462265 | 0 | AL amyloidosis | 0.4629911629562602 | ||
| P13500 | CCL2 | C-C motif chemokine 2 | Tier 1 | 0.584 | 1 | A_assoc | 14 | 86.94 | 1 | 0 | 1 | 34 | 42007960, 41360349, 41207524, 39422353, 39317671, 38016488, 34440571, 32784904, 31267721, 31039360, 30056058, 29111236, 28385802, 28315675, 28186566, 27878687, 27392463, 26868748, 25970072, 25901662, 25457849, 25457848, 25236655, 24694577, 24561613, 24481979, 21813474, 21147843, 19156777, 18997060, 18776253, 18258851, 11591377, 36508319 | 0 | Crohn's disease | 0.44619484388731423 | ||
| Q63HQ2 | EGFLAM | Pikachurin | Tier 1.5 | 0.574 | 1 | A_assoc | 3 | 80.56 | 1 | 0 | 0 | 0 | 0 | mathematical ability | 0.41387833248094535 | |||
| Q8NEV9 | IL27 | Interleukin-27 subunit alpha | Tier 1.5 | 0.573 | 1 | A_assoc | 4 | 75.62 | 1 | 0 | 1 | 2 | 35859339, 32784904 | 0 | Crohn's disease | 0.40963715551754365 | ||
| P01275 | GCG | Pro-glucagon | Tier 1 | 0.562 | 1 | A_assoc | 42 | 68.94 | 1 | 0 | 1 | 4 | 40563394, 37298475, 22915350, 22658959 | 0 | psoriasis | 0.37425807740488537 | ||
| P06850 | CRH | Corticoliberin | Tier 1 | 0.562 | 1 | A_assoc | 5 | 61.97 | 1 | 0 | 0 | 0 | 0 | autosomal dominant nocturnal frontal lobe epilepsy | 0.37224647599732263 | |||
| P48061 | CXCL12 | Stromal cell-derived factor 1 | Tier 1 | 0.56 | 1 | A_assoc | 34 | 83.25 | 1 | 0 | 1 | 36 | 41951573, 41931849, 41907643, 41527798, 40401615, 40008515, 39865939, 39263947, 38806504, 38477735, 32784904, 31267721, 31097627, 30465210, 30385042, 29111236, 28963140, 28670693, 27940247, 27924617, 27392463, 26265085, 25560701, 25236655, 24526776, 24277076, 23615526, 22376154, 21147843, 41963275 | 0 | HIV-1 infection | 0.3675509850165065 | ||
| Q7L8A9 | VASH1 | Tubulinyl-Tyr carboxypeptidase 1 | Tier 1 | 0.559 | 1 | A_assoc | 14 | 78.25 | 1 | 0 | 0 | 0 | 0 | Abnormality of the skeletal system | 0.36366533692746233 | |||
| P18509 | ADCYAP1 | Pituitary adenylate cyclase-activating polypeptide | Tier 1 | 0.559 | 1 | A_assoc | 12 | 62.56 | 1 | 0 | 0 | 0 | 0 | alcohol drinking | 0.36407172744864225 | |||
| P01282 | VIP | VIP peptides | Tier 1.5 | 0.55 | 1 | A_assoc | 5 | 67.62 | 1 | 0 | 1 | 24 | 41292425, 40957130, 40403614, 40056883, 39952883, 38763821, 37527574, 36669289, 36129574, 35879297, 35436736, 33990848, 33688885, 31689596, 31403149, 30167802, 30069577, 29708252, 28441340, 27542489, 27334718, 27088368, 26802746, 25782595 | 0 | uterine fibroid | 0.3332844575068197 | ||
| P61278 | SST | Somatostatin | Tier 1 | 0.549 | 1 | A_assoc | 10 | 65.81 | 1 | 0 | 1 | 14 | 41851736, 41043050, 40363817, 39451684, 37992929, 31793775, 19755178, 38709872, 37198662, 30644734, 28542563, 20388107, 17585951, 21625282 | 0 | Abruptio Placentae | 0.32971414126477894 | ||
| P01303 | NPY | Pro-neuropeptide Y | Tier 1 | 0.548 | 1 | A_assoc | 10 | 75.62 | 1 | 0 | 1 | 8 | 40040002, 38709872, 38654828, 38033269, 33297678, 29923734, 15984861, 11756401 | 0 | Nephropathy | 0.3251645152074003 | ||
| P20809 | IL11 | Interleukin-11 | Tier 1 | 0.545 | 1 | A_assoc | 8 | 82.62 | 1 | 0 | 1 | 8 | 39408993, 39263947, 28791655, 27878687, 25696907, 24629635 | 0 | osteoarthritis, hip | 0.31754029889853136 | ||
| O15240 | VGF | Neurosecretory protein VGF | Tier 1 | 0.545 | 1 | A_assoc | 5 | 60.44 | 1 | 0 | 0 | 0 | 0 | Abnormality of the skeletal system | 0.3156209584671744 | |||
| P0DMC3 | APELA | Apelin receptor early endogenous ligand | Tier 1 | 0.544 | 1 | A_assoc | 3 | 72.56 | 1 | 0 | 0 | 0 | 0 | attention deficit hyperactivity disorder | 0.3148526492327248 | |||
| O14960 | LECT2 | Leukocyte cell-derived chemotaxin-2 | Tier 1.5 | 0.542 | 1 | A_assoc | 4 | 92.44 | 1 | 0 | 1 | 2 | 35045701 | 0 | neurodegenerative disease | 0.30565036648724025 | ||
| P48645 | NMU | Neuromedin-U | Tier 1 | 0.541 | 1 | A_assoc | 3 | 62.72 | 1 | 0 | 1 | 2 | 32339148, 30826654 | 0 | hypertension | 0.30207473951583863 | ||
| Q06141 | REG3A | Regenerating islet-derived protein 3-alpha | Tier 1.5 | 0.539 | 1 | A_assoc | 4 | 89.0 | 1 | 0 | 1 | 2 | 39695715, 24771595 | 0 | alcohol drinking | 0.29724052454892086 | ||
| P30990 | NTS | Neurotensin/neuromedin N | Tier 1 | 0.53 | 1 | A_assoc | 11 | 61.34 | 1 | 0 | 1 | 38 | 41846533, 41572478, 41548876, 41047530, 40992279, 40326235, 39631853, 39413601, 38897014, 38131768, 36907299, 36735817, 36228172, 36222059, 36084454, 36067715, 35926421, 35279502, 34971987, 34215054, 33412470, 33404751, 32558232, 31919610, 31187249, 31163397, 30771936, 30724076, 30339976, 26916821, 26382019, 32260691, 20597503, 19740763, 18082623, 17150545, 12054450, 9425088 | 0 | Alzheimer disease | 0.26512620584304225 | ||
| P15018 | LIF | Leukemia inhibitory factor | Tier 1 | 0.523 | 1 | A_assoc | 5 | 87.12 | 1 | 0 | 1 | 38 | 41611413, 38359901, 37549567, 37175248, 36838669, 33640806, 32253765, 31791592, 31357280, 30771937, 30037541, 29289340, 28963578, 28763192, 27855943, 26877178, 26764106, 26695234, 26344338, 26113415, 25335821, 25311485, 25035238, 24716781, 22648816, 22471443, 27335672, 20673578, 20151395, 19803140, 18646283, 17315151, 16331583, 16053313, 11791582, 9823713, 39571081, 31461490 | 0 | alcohol drinking | 0.24197086949132446 | ||
| P01350 | GAST | Gastrin | Tier 1 | 0.523 | 1 | A_assoc | 4 | 64.88 | 1 | 0 | 1 | 2 | 41810845, 23179274 | 0 | neurodegenerative disease | 0.24399028152288016 | ||
| M5A8F1 | ERVH48-1 | Suppressyn | Tier 1.5 | 0.519 | 1 | A_assoc | 1 | 74.94 | 1 | 0 | 0 | 0 | 0 | hypertension | 0.23115391486595976 | |||
| P01178 | OXT | Oxytocin-neurophysin 1 | Tier 1.5 | 0.514 | 1 | A_assoc | 4 | 83.81 | 1 | 0 | 1 | 1 | 34649198 | 0 | neurodegenerative disease | 0.21368454441108417 | ||
| Q5T4W7 | ARTN | Artemin | Tier 1.5 | 0.512 | 1 | A_assoc | 5 | 75.0 | 1 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.20507822956537197 | |||
| P01286 | GHRH | Somatoliberin | Tier 1 | 0.51 | 1 | A_assoc | 3 | 77.75 | 1 | 0 | 1 | 1 | 35061691 | 0 | urinary tract obstruction | 0.2012239584361017 | ||
| P09683 | SCT | Secretin | Tier 1.5 | 0.495 | 1 | A_assoc | 3 | 65.88 | 1 | 0 | 1 | 2 | 17495522, 7752141 | 0 | idiopathic pulmonary fibrosis | 0.14866387905285056 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;